Erratum: Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer (Cell (2023) 186(16) (3476–3498.e35), (S0092867423007377), (10.1016/j.cell.2023.07.004))

Shrabanti Chowdhury, Jacob J. Kennedy, Richard G. Ivey, Oscar D. Murillo, Noshad Hosseini, Xiaoyu Song, Francesca Petralia, Anna Calinawan, Sara R. Savage, Anna B. Berry, Boris Reva, Umut Ozbek, Azra Krek, Weiping Ma, Felipe da Veiga Leprevost, Jiayi Ji, Seungyeul Yoo, Chenwei Lin, Uliana J. Voytovich, Yajue HuangSun Hee Lee, Lindsay Bergan, Travis D. Lorentzen, Mehdi Mesri, Henry Rodriguez, Andrew N. Hoofnagle, Zachary T. Herbert, Alexey I. Nesvizhskii, Bing Zhang, Jeffrey R. Whiteaker, David Fenyo, Wilson McKerrow, Joshua Wang, Stephan C. Schürer, Vasileios Stathias, X. Steven Chen, Mary Helen Barcellos-Hoff, Timothy K. Starr, Boris J. Winterhoff, Andrew C. Nelson, Samuel C. Mok, Scott H. Kaufmann, Charles Drescher, Marcin Cieslik, Pei Wang, Michael J. Birrer, Amanda G. Paulovich

Research output: Contribution to journalComment/debate


In the version of this article that was originally published on August 3, 2023, the supplemental figure legends were incorrect in many places, with some of the supplemental figure panels in the article lacking legends entirely. The proper supplemental figure legends now appear with the article online. The authors regret these errors and apologize for any inconvenience or confusion caused.

Original languageEnglish
Pages (from-to)1016
Number of pages1
Issue number4
StatePublished - 15 Feb 2024


Dive into the research topics of 'Erratum: Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer (Cell (2023) 186(16) (3476–3498.e35), (S0092867423007377), (10.1016/j.cell.2023.07.004))'. Together they form a unique fingerprint.

Cite this